{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T09:46:23Z","timestamp":1648633583770},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T00:00:00Z","timestamp":1398384000000},"content-version":"vor","delay-in-days":3767,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2004]]},"DOI":"10.1016\/s0212-6567(04)79451-2","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T18:18:34Z","timestamp":1365013114000},"page":"48-54","source":"Crossref","is-referenced-by-count":1,"title":["Evaluaci\u00f3n de un programa de seguimiento farmacoterap\u00e9utico a diab\u00e9ticos tipo 2"],"prefix":"10.1016","volume":"34","author":[{"given":"J.A.","family":"Fornos P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Guerra Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.F.","family":"Andr\u00e9s Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Egea Ibern\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0212-6567(04)79451-2_bib0005","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diacare.20.4.534","article-title":"Prevalence of diabetes and impaired glucose tolerance in Aragon, Spain","volume":"20","author":"Tamayo-Marco","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0015","series-title":"Gu\u00eda para el tratamiento de la diabetes tipo 2 en la Atenci\u00f3n Primaria","year":"2000"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0020","series-title":"A nosa sa\u00fade en cifras. Ano 2000","author":"Medina","year":"2001"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0025","first-page":"197","article-title":"coordinadores. Proyecto COMBO. Criterios y pautas de la terapia combinada en la diabetes tipo 2. Documento de consenso","volume":"27","author":"Goday","year":"2001","journal-title":"Aten Primaria"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0030","first-page":"175","article-title":"Segundo Consenso de Granada sobre Problemas Relacionados con Medicamentos","volume":"43","author":"Comit\u00e9 de Consenso","year":"2002","journal-title":"Ars Pharmaceutica"},{"issue":"Supl 1","key":"10.1016\/S0212-6567(04)79451-2_bib0035","first-page":"44","article-title":"Correspondencia entre indicadores cl\u00ednicos de resultados y calidad de vida percibida por pacientes diab\u00e9ticos, hipertensos y EPOC en Atenci\u00f3n Primaria","volume":"30","author":"Leiva","year":"2002","journal-title":"Aten Primaria"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0040","first-page":"35","article-title":"Screening, monitoring, and educating patients with diabetes in an independent community pharmacy in Puerto Rico","volume":"20","author":"Jim\u00e9nez","year":"2001","journal-title":"PR Health Sci J"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/014572179502100207","article-title":"Developing and implementing a pharmaceutical care model in an ambulatory care setting for patients with diabetes","volume":"21","author":"Van Veldhuizen","year":"1995","journal-title":"Diabetes Educ"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/106002809603000305","article-title":"Evaluation of a pharmaceutical care model on diabetes management","volume":"30","author":"Jaber","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0055","first-page":"62","article-title":"Resultados del Proyecto Triana. Seguimiento farmacoterap\u00e9utico en el paciente diab\u00e9tico de la provincia de Sevilla","volume":"3","author":"Pe\u00f1a","year":"2001","journal-title":"Pharm Care Esp"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1590\/S1135-57272001000400011","article-title":"Atenci\u00f3n farmac\u00e9utica en personas que han sufrido episodios coronarios agudos (Estudio TOMCOR)","volume":"75","author":"\u00c1lvarez","year":"2001","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0065","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archinte.162.10.1149","article-title":"A randomized trial of the effect of community pharmacists intervention on cholesterol risk management. The study of cardiovascular risk intervention (SCRIP)","volume":"162","author":"Tsuyuki","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1086-5802(16)31278-5","article-title":"Improving drug therapy for patients with asthma. Part I: Patient outcomes","volume":"41","author":"Herborg","year":"2001","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0075","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/00912700122010438","article-title":"Pharmaceutical care services for asthma patients: a controlled intervention study","volume":"41","author":"Shulz","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0212-6567(02)79052-5","article-title":"Reflexiones sobre la investigaci\u00f3n de resultados en salud","volume":"30","author":"Bad\u00eda","year":"2002","journal-title":"Aten Primaria"},{"key":"10.1016\/S0212-6567(04)79451-2_bib0085","first-page":"72","article-title":"Dise\u00f1o y validaci\u00f3n de un cuestionario de conocimiento de diabetes en oficina de farmacia","volume":"5","author":"Fornos","year":"2003","journal-title":"Pharm Care Esp"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656704794512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656704794512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T11:25:24Z","timestamp":1539775524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656704794512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004]]}},"alternative-id":["S0212656704794512"],"URL":"https:\/\/doi.org\/10.1016\/s0212-6567(04)79451-2","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2004]]}}}